Fusing serum peptidome profiles with clinical variables via machine learning for pulmonary embolism risk assessment
Abstract
No abstract availableKeywords
Funding Information
- Fudan University (2024MHPY08)
- National Natural Science Foundation of China (22525401)
- National Natural Science Foundation of China (22404028)
- Shanghai Municipal Health Commission (20244Y0183)
This publication has 36 references indexed in Scilit:
- Twenty-Five Years of High-Throughput Screening of Biological Samples with Mass Spectrometry: Current Platforms and Emerging MethodsAnalytical Chemistry, 2025
- Identification of Potential Urine Biomarkers of Hypertensive Nephropathy for Predicting Disease Progression Based on Metabolomics and PeptidomicsJournal of Proteome Research, 2025
- Elevated plasma complement factor H related 5 protein is associated with venous thromboembolismNature Communications, 2023
- Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical PatientsJAMA Network Open, 2022
- Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolismJournal of Thrombosis and Thrombolysis, 2022
- Rapid Detection of COVID-19 Using MALDI-TOF-Based Serum Peptidome ProfilingAnalytical Chemistry, 2021
- Red cell distribution width in acute pulmonary embolism patients: A simple aid for improvement of the 30-day mortality risk stratification based on the pulmonary embolism severity indexHeart & Lung, 2019
- Pulmonary embolismNature Reviews Disease Primers, 2018
- Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort studyThe Lancet, 2017
- Thrombosis as an intravascular effector of innate immunityNature Reviews Immunology, 2012